DB Biotech, a.s.
Slovakia SK-MF-000051838 Last updated 17 Sep 2026
- Devices
- 278
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Anti-p53 Ref DB 026-0.5
Anti-Desmin Ref DB 148-1
Anti-Cerb-2 Ref DB 094-0.5
Anti-Thyroglobulin Ref DB 259-1
Anti-S-100 Ref DB 055-0.1
Anti-BRAF Ref DB 159-1
Anti-Giardin α-1 Ref DB 319-1
Anti-CD23 Ref DB 135-0.5
Anti-p53 Ref DB 026-1
Anti-Cytokeratin 14 Ref DB 099-RTU-7
Anti-Cadherin1 (E-cadherin, CD324) Ref DB 265-0.2
Anti-b-actin Ref DB 001-IHC-0.1
Anti-Human IgG Ref DB 174-0.5
Anti-CD1a Ref DB 071-RTU-15
Anti-CD34 Ref DB 151-RTU-7
Anti-Cytokeratin 8 Ref DB 098-0.2
Anti-EGFR Ref DB 092-0.1
Anti-CD8 Ref DB 085-0.1
Anti-Cerb-2 Ref DB 094-RTU-7
Anti-Melanosome Ref DB 049-0.2
Anti-EBV/LMP-1 Ref DB 060-0.5
Anti-Human SOX10 Ref DB 260-RTU-15
Anti-EGFR Ref DB 092-1
Anti-Cerb-2 Ref DB 094-0.2
Anti-C3d complement Ref DB 106-0.5
DB Antigen retrieval solution, pH6, 10xconcentrated Ref DB Retris - 250
Anti-PR (Progesterone Receptor) Ref DB 109-0.5
Anti-Cytokeratin 16 Ref DB 100-1
Anti-Ki-67 Ref DB 318-RTU-7
Anti-Cytokeratin 5/6 Ref DB 097-0.2
Anti-Cadherin1 (E-cadherin, CD324) Ref DB 265-0.1
Anti-EGFR Ref DB 092-RTU-15
Anti-Human Kappa Light Chain Ref DB 037-RTU-7
Anti-Cytokeratin 14 Ref DB 099-0.1
Anti-p16 (mouse monoclonal) Ref DB 253-RTU-7
Anti-CD8 Ref DB 085-0.2
Anti-p16 (mouse monoclonal) Ref DB 253-1
Anti-Human SOX10 Ref DB 260-0.2
Anti-Desmin Ref DB 148-RTU-7
Anti-Cytokeratin 8 Ref DB 098-RTU-15
Anti-Cytokeratin 17 Ref DB 101-0.5
Anti-p63 Ref DB 134-RTU-7
Anti-BRAF Ref DB 159-RTU-15
Anti-Human IgG Ref DB 173-0.1
Anti-EBV/LMP-1 Ref DB 060-RTU-15
Anti-Thyroglobulin Ref DB 259-RTU-7
Anti-Cytokeratin 8 Ref DB 098-RTU-7
Anti-Cytokeratin 19 Ref DB 103-RTU-15
Anti-Cytokeratin 17 Ref DB 101-RTU-7
Anti-Synaptophysin Ref DB 156-0.5
Showing 101-150 of 278
About
Antibodies specially developed for IHC, WB and flow cytometry application. All rabbit clonal antibodies are developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DB Biotech scientific team.
What DB Biotech, a.s. makes
DB Biotech produces monoclonal antibodies targeting specific antigens for use in immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These include Anti-EBV/LMP-1, Anti-CD21, Anti-EGFR, Anti-Chromogranin A, Anti-Human Kappa Light Chain, Anti-EMA (CD227/Mucin-1), Anti-PSA, Anti-CD7, Anti-Human IgG, and Anti-CD8. The antibodies are designed for diagnostic applications in laboratory settings.
The company’s antibody portfolio is classified under EU medical device regulations as Class A and Class C, with devices registered in the EU’s eudamed database. DB Biotech is based in Slovakia.
Frequently asked questions
What types of medical devices does DB Biotech, a.s. manufacture?
DB Biotech, a.s. specializes in producing monoclonal antibodies designed for diagnostic use. These antibodies target specific antigens such as EBV/LMP-1, CD21, EGFR, Chromogranin A, and others, and are intended for applications like immunohistochemistry (IHC), Western blotting (WB), and flow cytometry. These products are developed to assist in laboratory-based diagnostic testing.
Where is DB Biotech, a.s. based?
DB Biotech, a.s. is headquartered in Slovakia. The company’s location is relevant for regulatory compliance, as it operates within the EU’s medical device framework, including registration in the eudamed database.
Which regulatory registries list DB Biotech’s devices?
DB Biotech’s medical devices are listed in the eudamed database, which is the official EU registry for medical devices. This registry ensures transparency and traceability of devices authorized under EU medical device regulations.
How are DB Biotech’s devices classified under EU regulations?
DB Biotech’s monoclonal antibodies fall under Class A and Class C classifications in the EU’s medical device regulatory framework. The classification depends on factors like the intended use, risk associated with the device, and the clinical significance of the diagnostic result. Class C devices are typically higher-risk diagnostic products, while Class A devices pose minimal risk.
Information
- Country
- Slovakia
- Address
- 80, Popradská, Košice, Slovakia
- Website
- www.dbbiotech.com
- [email protected]
- PRRC contact
- Martina Maďarová
- EUDAMED SRN
- SK-MF-000051838